What was the event about?
There is always something about each of the PharmaSynergy meetings that creates a great deal of excitement among the BD&L pharma community: be it the speakers that present, the topics that are covered, or the networking and business opportunities that the event provides.
Traditionally, the winter edition of the PharmaSynergy is focusing on stimulating B2B partnership meetings, targeting growth & mature regions. Pharma companies with a product portfolio in Rx, generics, branded, niche & value-added medicines & injectables are invited to network.
Key topics in 2023
All our events offer a full conference programme with professional and relevant content that adds value and provides useful information.
- Growth strategies through an economic turmoil: strategy & portfolio considerations
- Geo outlook by regional companies: go-to-market analytics, trends & developments in selected growth regions
- Partnerships for Value-Added and Patient-Centric Innovations
Thank you to all the companies who joined PharmaSynergy in 2023
With pharma companies coming from over 45+ countries, PharmaSynergy 2023 was a truly international B2B event.
We were delighted to see companies discussing licensing and partnership opportunities for Europe, Noth America, Africa, LATAM, CEE, MENA, and APAC.
We are committed to reaching out to the broader BD&L community across the globe and hope that by bringing together like-minded people, we are helping to create connections that are truly beneficial to our attendees.
With over 1200 partnering 1-2-1 meetings completed, PharmaSynergy 2023 was an engaging and dynamic event.
Keep checking our web-site to stay tuned